Kumar Neil sold BBIO
February 16, 2026 · Form 4 insider transaction
Kumar Neil sold 30,970 shares of BridgeBio Pharma, Inc. at $75.25 per share, a transaction worth $2.33M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
30,970
Price
$75.25
Total value
$2.33M
InsiderKumar Neil
RoleOfficer, Director
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 16, 2026
Filing dateFebruary 18, 2026
Shares owned after262,504
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 64,698 shares of Common Stock underlying the Reporting Person's RSUs.